IBDEI1O0 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27856,1,3,0)
 ;;=3^Family Hx of Colonic Polyps
 ;;^UTILITY(U,$J,358.3,27856,1,4,0)
 ;;=4^Z83.71
 ;;^UTILITY(U,$J,358.3,27856,2)
 ;;=^5063386
 ;;^UTILITY(U,$J,358.3,27857,0)
 ;;=Z84.81^^132^1321^29
 ;;^UTILITY(U,$J,358.3,27857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27857,1,3,0)
 ;;=3^Family Hx of Genetic Disease
 ;;^UTILITY(U,$J,358.3,27857,1,4,0)
 ;;=4^Z84.81
 ;;^UTILITY(U,$J,358.3,27857,2)
 ;;=^5063392
 ;;^UTILITY(U,$J,358.3,27858,0)
 ;;=Z86.010^^132^1321^76
 ;;^UTILITY(U,$J,358.3,27858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27858,1,3,0)
 ;;=3^Personal Hx of Colonic Polyps
 ;;^UTILITY(U,$J,358.3,27858,1,4,0)
 ;;=4^Z86.010
 ;;^UTILITY(U,$J,358.3,27858,2)
 ;;=^5063456
 ;;^UTILITY(U,$J,358.3,27859,0)
 ;;=Z86.14^^132^1321^81
 ;;^UTILITY(U,$J,358.3,27859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27859,1,3,0)
 ;;=3^Personal Hx of MRSA Infection
 ;;^UTILITY(U,$J,358.3,27859,1,4,0)
 ;;=4^Z86.14
 ;;^UTILITY(U,$J,358.3,27859,2)
 ;;=^5063464
 ;;^UTILITY(U,$J,358.3,27860,0)
 ;;=Z86.31^^132^1321^77
 ;;^UTILITY(U,$J,358.3,27860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27860,1,3,0)
 ;;=3^Personal Hx of Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,27860,1,4,0)
 ;;=4^Z86.31
 ;;^UTILITY(U,$J,358.3,27860,2)
 ;;=^5063467
 ;;^UTILITY(U,$J,358.3,27861,0)
 ;;=Z86.711^^132^1321^107
 ;;^UTILITY(U,$J,358.3,27861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27861,1,3,0)
 ;;=3^Personal Hx of Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,27861,1,4,0)
 ;;=4^Z86.711
 ;;^UTILITY(U,$J,358.3,27861,2)
 ;;=^5063474
 ;;^UTILITY(U,$J,358.3,27862,0)
 ;;=Z86.72^^132^1321^113
 ;;^UTILITY(U,$J,358.3,27862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27862,1,3,0)
 ;;=3^Personal Hx of Thrombophlebitis
 ;;^UTILITY(U,$J,358.3,27862,1,4,0)
 ;;=4^Z86.72
 ;;^UTILITY(U,$J,358.3,27862,2)
 ;;=^5063476
 ;;^UTILITY(U,$J,358.3,27863,0)
 ;;=Z87.310^^132^1321^105
 ;;^UTILITY(U,$J,358.3,27863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27863,1,3,0)
 ;;=3^Personal Hx of Osteoporosis Fx
 ;;^UTILITY(U,$J,358.3,27863,1,4,0)
 ;;=4^Z87.310
 ;;^UTILITY(U,$J,358.3,27863,2)
 ;;=^5063485
 ;;^UTILITY(U,$J,358.3,27864,0)
 ;;=Z87.442^^132^1321^116
 ;;^UTILITY(U,$J,358.3,27864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27864,1,3,0)
 ;;=3^Personal Hx of Urinary Calculi
 ;;^UTILITY(U,$J,358.3,27864,1,4,0)
 ;;=4^Z87.442
 ;;^UTILITY(U,$J,358.3,27864,2)
 ;;=^5063497
 ;;^UTILITY(U,$J,358.3,27865,0)
 ;;=Z87.81^^132^1321^114
 ;;^UTILITY(U,$J,358.3,27865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27865,1,3,0)
 ;;=3^Personal Hx of Traumatic Fx (Healed)
 ;;^UTILITY(U,$J,358.3,27865,1,4,0)
 ;;=4^Z87.81
 ;;^UTILITY(U,$J,358.3,27865,2)
 ;;=^5063513
 ;;^UTILITY(U,$J,358.3,27866,0)
 ;;=Z87.890^^132^1321^109
 ;;^UTILITY(U,$J,358.3,27866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27866,1,3,0)
 ;;=3^Personal Hx of Sex Reassignment
 ;;^UTILITY(U,$J,358.3,27866,1,4,0)
 ;;=4^Z87.890
 ;;^UTILITY(U,$J,358.3,27866,2)
 ;;=^5063517
 ;;^UTILITY(U,$J,358.3,27867,0)
 ;;=Z87.892^^132^1321^74
 ;;^UTILITY(U,$J,358.3,27867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27867,1,3,0)
 ;;=3^Personal Hx of Anaphylaxis
 ;;^UTILITY(U,$J,358.3,27867,1,4,0)
 ;;=4^Z87.892
 ;;^UTILITY(U,$J,358.3,27867,2)
 ;;=^5063519
 ;;^UTILITY(U,$J,358.3,27868,0)
 ;;=Z87.39^^132^1321^102
 ;;^UTILITY(U,$J,358.3,27868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27868,1,3,0)
 ;;=3^Personal Hx of Musculoskeletal/Connective Tissue Disease
 ;;^UTILITY(U,$J,358.3,27868,1,4,0)
 ;;=4^Z87.39
 ;;^UTILITY(U,$J,358.3,27868,2)
 ;;=^5063488
